Journal of Neuro-Oncology

, Volume 99, Issue 2, pp 227–236

Germinomas in the basal ganglia: magnetic resonance imaging classification and the prognosis

Authors

  • Ji Hoon Phi
    • Department of Neurosurgery, Seoul National University College of MedicineSeoul National University Hospital
  • Byung-Kyu Cho
    • Department of Neurosurgery, Seoul National University College of MedicineSeoul National University Hospital
  • Seung-Ki Kim
    • Department of Neurosurgery, Seoul National University College of MedicineSeoul National University Hospital
  • Jin Chul Paeng
    • Department of Nuclear MedicineSeoul National University College of Medicine, Seoul National University Hospital
  • In-One Kim
    • Department of Diagnostic Radiology, Seoul National University College of MedicineSeoul National University Hospital
  • Il Han Kim
    • Department of Radiation Oncology and Cancer Research InstituteSeoul National University College of Medicine, Seoul National University Hospital
  • Dong Gyu Kim
    • Department of Neurosurgery, Seoul National University College of MedicineSeoul National University Hospital
  • Hee-Won Jung
    • Department of Neurosurgery, Seoul National University College of MedicineSeoul National University Hospital
  • Jeong Eun Kim
    • Department of Neurosurgery, Seoul National University College of MedicineSeoul National University Hospital
    • Department of Neurosurgery, Seoul National University College of MedicineSeoul National University Hospital
Clinical Study - Patient Study

DOI: 10.1007/s11060-010-0119-7

Cite this article as:
Phi, J.H., Cho, B., Kim, S. et al. J Neurooncol (2010) 99: 227. doi:10.1007/s11060-010-0119-7

Abstract

Germinoma in the basal ganglia (BG) is notorious for its diagnostic difficulty. Clinical and radiological features of this disease are quite diverse, but have not been well characterized with respect to prognosis. We retrospectively reviewed the clinical course and treatment outcomes of 17 patients with a BG germinoma. The initial magnetic resonance imaging (MRI) features were classified. Clinical features and treatment outcomes were then analyzed with this classification scheme. A Type 1 lesion was defined as a subtle lesion with faint or no contrast enhancement (six patients). Type 2, 3, and 4 lesions were defined as contrast-enhancing lesions and were differentiated by the lesion size and the presence of subependymal seeding (11 patients). Type 1 lesions were distinct from the other lesions. Patients with a Type 1 lesion had a significantly longer time from the initial MRI to diagnosis than patients with Type 2, 3, and 4 lesions (P = 0.012). The actuarial progression-free survival and overall survival of patients 5 years after diagnosis were 66 and 77%, respectively. The presence of a Type 1 lesion (P = 0.004), a longer time delay in the diagnosis (P = 0.038), and radiation therapy without complete ventricular coverage (P = 0.010) were significantly associated with tumor progression. Profound motor deficits at diagnosis were associated with deterioration in motor function after tumor remission (P = 0.035). Early diagnosis of BG germinomas could affect the ability to control a tumor and neurological outcomes. In particular, high clinical suspicion and active diagnostic procedures are recommended. For optimal treatment, radiation fields should include entire ventricles even if there is no subependymal seeding.

Keywords

Germinoma Basal ganglia Magnetic resonance imaging Prognosis Motor function

Copyright information

© Springer Science+Business Media, LLC. 2010